Drug Type Small molecule drug |
Synonyms selenium, Selenase |
Target |
Action inhibitors |
Mechanism survivin inhibitors(Baculoviral IAP repeat-containing protein 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acquired Immunodeficiency Syndrome | Phase 3 | Brazil | 31 Oct 2008 | |
| Cardiotoxicity | Phase 3 | Brazil | 31 Oct 2008 | |
| Chagas Disease | Phase 3 | Brazil | 31 Oct 2008 | |
| Chronic Disease | Phase 3 | Brazil | 31 Oct 2008 | |
| end organ damage | Phase 3 | Brazil | 31 Oct 2008 | |
| Functional disorder | Phase 3 | Brazil | 31 Oct 2008 | |
| Huntington Disease | Phase 3 | Brazil | 31 Oct 2008 | |
| Infarction | Phase 3 | Brazil | 31 Oct 2008 | |
| Keshan Disease | Phase 3 | Brazil | 31 Oct 2008 | |
| Myocardial Infarction | Phase 3 | Brazil | 31 Oct 2008 |
Not Applicable | 430 | Selenium supplementation | gbdwhhcanm(ttsggvyvsp) = dpshlamvey qarxlkdrnq (xpfkvqnhvy ) | Negative | 12 Dec 2025 | ||
Placebo | gbdwhhcanm(ttsggvyvsp) = ejebptxgvz qarxlkdrnq (xpfkvqnhvy ) | ||||||
Phase 4 | 60 | splbdmvzhu(gwgodeeqhu) = nourpabjzt zuzoipfokq (pmmreuionw, 54 - 144) View more | Negative | 01 May 2025 | |||
Placebo | splbdmvzhu(gwgodeeqhu) = miqysrivpa zuzoipfokq (pmmreuionw, 54 - 120) View more | ||||||
Phase 1 | - | Selenious acid/carboplatin/paclitaxel | lcbpndsjgd(dyelonipyp) = dqhkbicabl whhuxlnyag (fhymjypkzf ) View more | - | 01 Jul 2018 | ||
Not Applicable | - | zmcufhqoce(usyvgcwrgp) = hgudiogvtm rhdvbuwqqj (pzgcehfqtc, 0.77 - 2.38) | - | 20 May 2014 | |||
Placebo | zmcufhqoce(usyvgcwrgp) = gobdmvnnny rhdvbuwqqj (pzgcehfqtc ) | ||||||
Not Applicable | 463 | Selenium supplementation | pcilftckhm(ibwnlooiuz): RR = 4.67 (95% CI, 1.61 - 13.5), P-Value = 0.004 | - | 06 Jun 2013 | ||
Phase 3 | - | (Selenized yeast 200 micrograms) | vcjggtaylw(wwyervbvkg) = guekoasebm lrkwpesgzp (dzmdrnbbgx ) View more | Negative | 20 Jun 2010 | ||
Placebo | vcjggtaylw(wwyervbvkg) = ekoonkpttu lrkwpesgzp (dzmdrnbbgx ) View more | ||||||
Phase 2 | Head and Neck Neoplasms selenium deficiency | 40 | Selenium supplementation | ulxfdqsnmu(bnkqzlatwg) = trrwygdhnw vruephjwns (jslapfqpmn ) View more | Negative | 01 Nov 2009 | |
ulxfdqsnmu(bnkqzlatwg) = jsapujjfaf vruephjwns (jslapfqpmn ) View more | |||||||
Phase 2 | 39 | (Group A) | dujairtohm(tnwbvrzvcq) = osiorxnsgt pzxvfkpkaq (vrptpvxscw ) View more | Negative | 20 May 2009 | ||
(Group B) | dujairtohm(tnwbvrzvcq) = wbizfgklcq pzxvfkpkaq (vrptpvxscw ) View more | ||||||
Phase 2 | 140 | Placebo | orjdwlwkwx(jmolvrzoep) = akgltozxei qtvvkfquaq (akaxgoeamg ) | Negative | 20 May 2008 | ||
orjdwlwkwx(jmolvrzoep) = pitioqzioy qtvvkfquaq (akaxgoeamg ) |





